loadpatents
name:-0.016626119613647
name:-0.0089430809020996
name:-0.0079030990600586
Miyakoshi; Akira Patent Filings

Miyakoshi; Akira

Patent Applications and Registrations

Patent applications and USPTO patent grants for Miyakoshi; Akira.The latest application filed is for "anti-human cd69 antibody, and use thereof for medical purposes".

Company Profile
7.11.14
  • Miyakoshi; Akira - Kashiwa JP
  • Miyakoshi; Akira - Kashiwa-shi JP
  • Miyakoshi; Akira - Chiba N/A JP
  • Miyakoshi; Akira - Tokyo JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-human CD69 antibody, and use thereof for medical purposes
Grant 10,865,247 - Kojoh , et al. December 15, 2
2020-12-15
Anti-human Cd69 Antibody, And Use Thereof For Medical Purposes
App 20200199235 - Kojoh; Kanehisa ;   et al.
2020-06-25
Human antibody against aggrecanase-type ADAMTS species for therapeutics of aggrecanase-related diseases
Grant 10,640,573 - Miyakoshi , et al.
2020-05-05
Anti-ADAM28 antibody for treating cancer
Grant 10,556,967 - Miyakoshi , et al. Feb
2020-02-11
Anti-human Cd69 Antibody, And Use Thereof For Medical Purposes
App 20190233521 - KOJOH; Kanehisa ;   et al.
2019-08-01
Human Antibody Against Aggrecanase-type Adamts Species For Therapeutics Of Aggrecanase-related Diseases
App 20190233541 - MIYAKOSHI; Akira ;   et al.
2019-08-01
Anti-human membrane-type ADAM28 antibody
Grant 10,329,358 - Miyakoshi , et al.
2019-06-25
Anti-adam28 Antibody For Treating Cancer
App 20180155448 - MIYAKOSHI; Akira ;   et al.
2018-06-07
Anti-human Membrane-type Adam28 Antibody
App 20180044435 - MIYAKOSHI; Akira ;   et al.
2018-02-15
Anti-ADAM28 antibody for treating cancer
Grant 9,845,364 - Miyakoshi , et al. December 19, 2
2017-12-19
RNF8-FHA domain-modified protein and method of producing the same
Grant 9,493,523 - Kojoh , et al. November 15, 2
2016-11-15
Human Antibody Against Aggrecanase-type Adamts Species For Therapeutics Of Aggrecanase-related Diseases
App 20160304622 - MIYAKOSHI; Akira ;   et al.
2016-10-20
Anti-adam28 Antibody For Treating Cancer
App 20150274840 - Miyakoshi; Akira ;   et al.
2015-10-01
High-speed maturation method for an oligonucleotide library for the purpose of preparing a protein library
Grant 9,133,452 - Ueda , et al. September 15, 2
2015-09-15
Anti-human Cd69 Antibody, And Use Thereof For Medical Purposes
App 20150118237 - Kojoh; Kanehisa ;   et al.
2015-04-30
High-speed Maturation Method For An Oligonucleotide Library For The Purpose Of Preparing A Protein Library
App 20130143773 - Ueda; Takuya ;   et al.
2013-06-06
Rnf8-fha Domain-modified Protein And Method Of Producing The Same
App 20130143299 - Kojoh; Kanehisa ;   et al.
2013-06-06
Method for forming a dielectric film
Grant 6,852,646 - Yoshioka , et al. February 8, 2
2005-02-08
Plasma display panel and fabrication method thereof
Grant 6,734,626 - Yoshioka , et al. May 11, 2
2004-05-11
Method for forming a dielectric film
App 20030013244 - Yoshioka, Toshihiro ;   et al.
2003-01-16
Plasma display panel and fabrication method thereof
App 20020008475 - Yoshioka, Toshihiro ;   et al.
2002-01-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed